V. Shane Pankratz

52.9k total citations · 4 hit papers
337 papers, 23.2k citations indexed

About

V. Shane Pankratz is a scholar working on Epidemiology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, V. Shane Pankratz has authored 337 papers receiving a total of 23.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Epidemiology, 68 papers in Oncology and 68 papers in Psychiatry and Mental health. Recurrent topics in V. Shane Pankratz's work include Dementia and Cognitive Impairment Research (58 papers), Virology and Viral Diseases (42 papers) and Global Cancer Incidence and Screening (37 papers). V. Shane Pankratz is often cited by papers focused on Dementia and Cognitive Impairment Research (58 papers), Virology and Viral Diseases (42 papers) and Global Cancer Incidence and Screening (37 papers). V. Shane Pankratz collaborates with scholars based in United States, Belarus and Canada. V. Shane Pankratz's co-authors include Ronald C. Petersen, David S. Knopman, Rosebud O. Roberts, Yonas E. Geda, Bradley F. Boeve, Walter A. Rocca, Robert A. Vierkant, Clifford R. Jack, Robert J. Ivnik and Stephen D. Weigand and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

V. Shane Pankratz

328 papers receiving 22.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

2013 3.1k citations Clifford R. Jack, David S. Knopman et al. The Lancet Neurology profile →
Benign Breast Disease and the Risk of Breast Cancer

2005 628 citations Lynn C. Hartmann, Thomas A. Sellers et al. profile →
The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics

2008 616 citations Rosebud O. Roberts, Yonas E. Geda et al. profile →
Prevalence of mild cognitive impairment is higher in men

2010 566 citations Ronald C. Petersen, Rosebud O. Roberts et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Shane Pankratz United States	73	7.2k	6.3k	3.2k	3.2k	3.0k	337	23.2k
Rudi G. J. Westendorp Netherlands	92	3.4k 0.5×	6.2k 1.0×	4.0k 1.3×	1.2k 0.4×	1.7k 0.6×	577	30.7k
Richard J. Kryscio United States	76	3.9k 0.5×	4.5k 0.7×	2.1k 0.6×	2.0k 0.6×	4.4k 1.5×	356	22.6k
M. Arfan Ikram Netherlands	96	6.5k 0.9×	6.4k 1.0×	3.5k 1.1×	2.9k 0.9×	4.8k 1.6×	837	34.1k
Walter A. Rocca United States	99	10.2k 1.4×	6.9k 1.1×	3.2k 1.0×	2.7k 0.9×	1.5k 0.5×	347	33.2k
Laurel Beckett United States	78	9.3k 1.3×	6.5k 1.0×	2.7k 0.8×	4.5k 1.4×	1.6k 0.5×	292	23.5k
Cornelia M. van Duijn Netherlands	96	4.7k 0.7×	9.6k 1.5×	11.8k 3.7×	1.2k 0.4×	1.7k 0.5×	676	40.3k
Alfred Rademaker United States	97	3.4k 0.5×	3.7k 0.6×	3.9k 1.2×	1.7k 0.5×	6.7k 2.2×	639	30.6k
Harry V. Vinters United States	104	10.7k 1.5×	14.5k 2.3×	11.9k 3.7×	2.7k 0.9×	2.8k 0.9×	540	45.1k
Albert Hofman Netherlands	91	2.1k 0.3×	4.0k 0.6×	4.6k 1.4×	846 0.3×	2.7k 0.9×	360	31.4k
Reinhold Schmidt Germany	77	3.9k 0.5×	2.8k 0.5×	2.7k 0.8×	1.8k 0.6×	3.0k 1.0×	440	21.9k

Countries citing papers authored by V. Shane Pankratz

Since Specialization

Citations

This map shows the geographic impact of V. Shane Pankratz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Shane Pankratz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Shane Pankratz more than expected).

Fields of papers citing papers by V. Shane Pankratz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Shane Pankratz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Shane Pankratz. The network helps show where V. Shane Pankratz may publish in the future.

Co-authorship network of co-authors of V. Shane Pankratz

This figure shows the co-authorship network connecting the top 25 collaborators of V. Shane Pankratz. A scholar is included among the top collaborators of V. Shane Pankratz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Shane Pankratz. V. Shane Pankratz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steinkamp, Mara P., Irina V. Lagutina, Yan Guo, et al.. (2025). Novel p53 reactivators that are synergistic with olaparib for the treatment of gynecologic cancers with mutant p53. Translational Oncology. 61. 102522–102522.

Pankratz, V. Shane, et al.. (2024). Perceived risk for screen-detectable cancers among american indian adults in the zuni pueblo, USA: Insights and implications for intervention programs. Preventive Medicine Reports. 49. 102950–102950.

Cook, David A., et al.. (2024). External Versus Internal Focus of Attention in Procedural Skills Learning: A Randomized Study. Academic Medicine. 100(3). 319–324.

Pankratz, V. Shane, et al.. (2023). Cervical Cancer Knowledge and Screening Patterns in Zuni Pueblo Women in the Southwest United States. Journal of Cancer Education. 38(5). 1531–1538. 4 indexed citations

Pankratz, V. Shane, Kevin English, Prajakta Adsul, et al.. (2022). American Indian/Alaska Native and black colon cancer patients have poorer cause-specific survival based on disease stage and anatomic site of diagnosis. Cancer Epidemiology. 80. 102229–102229. 5 indexed citations

Pankratz, V. Shane, Kevin English, Prajakta Adsul, et al.. (2022). Colorectal Cancer Survival Trends in the United States From 1992 to 2018 Differ Among Persons From Five Racial and Ethnic Groups According to Stage at Diagnosis: A SEER-Based Study. Cancer Control. 29. 2905554488–2905554488. 13 indexed citations

Engmann, Natalie J., Christopher G. Scott, Matthew R. Jensen, et al.. (2019). Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition. Cancer Epidemiology Biomarkers & Prevention. 28(8). 1324–1330. 16 indexed citations

Engmann, Natalie J., Christopher G. Scott, Matthew R. Jensen, et al.. (2017). Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors. Cancer Epidemiology Biomarkers & Prevention. 26(6). 930–937. 36 indexed citations

Pankratz, V. Shane, Ana I. Velázquez, Jeremiah A. Aakre, et al.. (2015). Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients. Journal of the Neurological Sciences. 349(1-2). 124–128. 51 indexed citations

10.

Roberts, Rosebud O., David S. Knopman, H. Ruth, et al.. (2014). Diabetes and Elevated Hemoglobin A1c Levels Are Associated with Brain Hypometabolism but Not Amyloid Accumulation. Journal of Nuclear Medicine. 55(5). 759–764. 133 indexed citations

11.

Bertrand, Kimberly A., Rulla M. Tamimi, Christopher G. Scott, et al.. (2013). Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Research. 15(6). R104–R104. 141 indexed citations

12.

Jack, Clifford R., David S. Knopman, William J. Jagust, et al.. (2013). Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. The Lancet Neurology. 12(2). 207–216. 3084 indexed citations breakdown →

13.

Guidugli, Lucia, V. Shane Pankratz, Namit Singh, et al.. (2012). A Classification Model for BRCA2 DNA Binding Domain Missense Variants Based on Homology-Directed Repair Activity. Cancer Research. 73(1). 265–275. 89 indexed citations

14.

Heine, John, Christopher G. Scott, Thomas A. Sellers, et al.. (2012). A Novel Automated Mammographic Density Measure and Breast  Cancer Risk. JNCI Journal of the National Cancer Institute. 104(13). 1028–1037. 64 indexed citations

15.

Pankratz, V. Shane, Zhifu Sun, Jeremiah A. Aakre, et al.. (2011). Systematic Evaluation of Genetic Variants in Three Biological Pathways on Patient Survival in Low-Stage Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(9). 1488–1495. 17 indexed citations

16.

Li, Yafei, Zhifu Sun, Julie M. Cunningham, et al.. (2011). Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non–Small Cell Lung Cancer Treated with Chemotherapy. Clinical Cancer Research. 17(11). 3830–3840. 22 indexed citations

17.

Radisky, Derek C., Marta Santisteban, Hal K. Berman, et al.. (2011). p16INK4a Expression and Breast Cancer Risk in Women with Atypical Hyperplasia. Cancer Prevention Research. 4(12). 1953–1960. 23 indexed citations

18.

Wu, Xianglin, Gourish Mondal, Xianshu Wang, et al.. (2009). Microcephalin Regulates BRCA2 and Rad51-Associated DNA Double-Strand Break Repair. Cancer Research. 69(13). 5531–5536. 43 indexed citations

19.

Vachon, Celine M., Thomas A. Sellers, Erin E. Carlson, et al.. (2007). Strong Evidence of a Genetic Determinant for Mammographic Density, a Major Risk Factor for Breast Cancer. Cancer Research. 67(17). 8412–8418. 58 indexed citations

20.

Consugar, Mark, Sarah Anderson, Sandro Rossetti, et al.. (2005). Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease. American Journal of Kidney Diseases. 45(1). 77–87. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact